Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT Connect 2020 Discussion: The VOYAGER PAD Study
Author(s): Mirvat Alasnag , Added: 3 years ago
Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, KSA) and Dr Connie N Hess (University of Colorado School of Medicine, Aurora, CO, US) discuss the results of the sub-analysis of the VOYAGER PAD Study. The VOYAGER PAD trial showed that rivaroxaban/aspirin was superior to aspirin at preventing major adverse limb and cardiovascular events. Dr Hess describes the design of the secondary… View more

Anticoagulation
AHA 2018: The DTU-STEMI Trial
Author(s): Navin K Kapur Added: 5 years ago
Prof Navin K. Kapur (Tufts Medical Center, Boston, US) discusses the DTU-STEMI trial - Mechanically unloading the left ventricular and delaying reperfusion in patients with anterior ST-segment elevation myocardial infarction. Filmed by Radcliffe Cardiology on site at AHA 2018. View more

MI/ACS
Evangelos Giannitsis
Job title: Assistant Professor of Medicine in Heidelberg
Dr. Giannitsis, an Assistant Professor of Medicine based in Heidelberg, holds a medical degree from the University of Homburg. He pursued advanced training in internal medicine and cardiology at Lübeck University Hospital in Germany. Additionally, he completed a Ph.D. in internal medicine before assuming his current role in 2002. Dr. Giannitsis's research is centered on cardiac biomarkers,… View more
Outcomes After PCI in Women
Author(s): Usha Rao , G Louise Buchanan , Angela Hoye Added: 3 years ago
Cardiovascular disease is a major cause of morbidity and is the leading cause of death in women and men in Western societies.1 Despite the major advances seen in the field of interventional cardiology and pharmacotherapy, which have translated into better outcomes, a disparity is evident in the clinical outcomes between men and women. This was clearly evident in a recent systematic review and… View more

Prevention & Chronic Conditions

Intervention
RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients
Author(s): Harald Thune Jorstad Added: 2 years ago
In this video, Dr Harald Thune Jorstad (Academic Medical Center, Amsterdam, NL) discusses the findings of RESPONSE-2, a randomised trial aiming to investigate the long-term outcomes of community-based lifestyle interventions in coronary artery disease (CAD) patients. The study showed that at 3 years follow-up, the benefits of 1 year of nurse-coordinated referral to community-based lifestyle… View more

Anticoagulation
Author(s): Edwin Lee , Ajay J Kirtane Added: 3 years ago
The outcomes of patients with ST-segment elevation myocardial infarction (STEMI) have improved in recent years with the more widespread adoption of definitive reperfusion therapies, including rapid recanalisation of the infarct-related artery with percutaneous coronary intervention (PCI). Nonetheless, despite the near universal restoration of normal epicardial flow following primary PCI for STEMI… View more

MI/ACS

Intervention
Author(s): Michael Tsang , Sanjit Jolly Added: 3 years ago
Many advances have been made in the management of ST elevation myocardial infarction (STEMI) over the past three decades.1 This is owed to insight into role that thrombus has in the obstruction of the infarct-related artery (IRA) and the subsequent cascade of the myocardial ischaemia, cell oedema and myocardial necrosis. The institution of reperfusion therapy has revolutionised the care of… View more

Anticoagulation

Standards & Guidelines
Author(s): Lieuwe H Piers , Maarten A Vink , Giovanni Amoroso Added: 3 years ago
The transradial approach (TRA) was introduced for the first time in 1989.1 Used at first by Campeau for coronary angiography, the TRA was later applied by Kiemeneij et al. for percutaneous coronary intervention (PCI).2 The radial artery has proven to be a challenging but safe route towards the coronary arteries. According to the European Society of Cardiology (ESC) guidelines, the radial artery… View more

Imaging & Diagnostics
Author(s): Timm Bauer , Christian Hamm Added: 3 years ago
Introduction Antiplatelet therapy is a cornerstone in coronary artery disease (CAD) management. Acetylsalicyclic acid (ASA) has been known for many decades to have antithrombotic efficacy. Already in the 1980’s, the ISIS-2 study demonstrated that ASA reduces mortality in acute myocardial infarction (AMI) by 23 %.1 ASA leads to irreversible inactivation of cyclooxygenase 1 and thereby blocks the… View more

Anticoagulation
Author(s): Kristina Grønborg Laut , Alma Becic Pedersen , Timothy L Lash , et al Added: 3 years ago
Coronary heart disease (CHD) remains a leading cause of mortality and disability for both men and women in Europe, accounting for 1.92 million deaths each year.1 One in five women (22%) and one in five men (21%) die from the disease.1 This significant burden necessitates ongoing improvements in patient management and treatment, to minimise the impact of cardiovascular conditions on both patients… View more

Standards & Guidelines

Prevention & Chronic Conditions